Arriving in the field of excess body fat management, retatrutide presents a different strategy. Unlike many current medications, retatrutide functions as a twin agonist, simultaneously affecting both GLP-like peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) receptors. This concurrent engagement promotes multiple helpful effects,… Read More